106 related articles for article (PubMed ID: 18453637)
1. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet.
Hu C; Dandapat A; Sun L; Chen J; Marwali MR; Romeo F; Sawamura T; Mehta JL
Cardiovasc Res; 2008 Jul; 79(2):287-93. PubMed ID: 18453637
[TBL] [Abstract][Full Text] [Related]
2. PAR4 Inhibition Reduces Coronary Artery Atherosclerosis and Myocardial Fibrosis in SR-B1/LDLR Double Knockout Mice.
Lee SK; Malik RA; Zhou J; Wang W; Gross PL; Weitz JI; Ramachandran R; Trigatti BL
Arterioscler Thromb Vasc Biol; 2023 Nov; 43(11):2165-2178. PubMed ID: 37675637
[TBL] [Abstract][Full Text] [Related]
3. Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis.
Shao JS; Sierra OL; Cohen R; Mecham RP; Kovacs A; Wang J; Distelhorst K; Behrmann A; Halstead LR; Towler DA
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1821-33. PubMed ID: 21597007
[TBL] [Abstract][Full Text] [Related]
4. Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis.
Doddapattar P; Dev R; Ghatge M; Patel RB; Jain M; Dhanesha N; Lentz SR; Chauhan AK
Circ Res; 2022 Apr; 130(9):1289-1305. PubMed ID: 35400205
[TBL] [Abstract][Full Text] [Related]
5. Deletion of vascular thromboxane A
Braun H; Hauke M; Petermann M; Eckenstaler R; Ripperger A; Schwedhelm E; Ludwig-Kraus B; Bernhard Kraus F; Jalal Ahmed Shawon M; Dubourg V; Zernecke A; Schreier B; Gekle M; Benndorf RA
Biochem Pharmacol; 2024 Jan; 219():115916. PubMed ID: 37979705
[TBL] [Abstract][Full Text] [Related]
6. AAV2/8-humanFOXP3 gene therapy shows robust anti-atherosclerosis efficacy in LDLR-KO mice on high cholesterol diet.
Cao M; Theus SA; Straub KD; Figueroa JA; Mirandola L; Chiriva-Internati M; Hermonat PL
J Transl Med; 2015 Jul; 13():235. PubMed ID: 26187646
[TBL] [Abstract][Full Text] [Related]
7. A Novel Cell-Free, Non-Fluorescent Method to Measure LOX-1-Binding Activity Corresponding to The Functional Activity of HDL.
Kakino A; Usami Y; Horiuchi S; Fujita Y; Kotani K; Chen CH; Okamura T; Sawamura T
J Atheroscler Thromb; 2019 Nov; 26(11):947-958. PubMed ID: 30944265
[TBL] [Abstract][Full Text] [Related]
8. Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol.
van Kuijk K; McCracken IR; Tillie RJHA; Asselberghs SEJ; Kheder DA; Muitjens S; Jin H; Taylor RS; Wichers Schreur R; Kuppe C; Dobie R; Ramachandran P; Gijbels MJ; Temmerman L; Kirkwoord PM; Luyten J; Li Y; Noels H; Goossens P; Wilson-Kanamori JR; Schurgers LJ; Shen YH; Mees BME; Biessen EAL; Henderson NC; Kramann R; Baker AH; Sluimer JC
Cardiovasc Res; 2023 Jul; 119(7):1509-1523. PubMed ID: 36718802
[TBL] [Abstract][Full Text] [Related]
9. Metyrapone Treatment Protects Low-Density Lipoprotein Receptor Knockout Mice against Hypercorticosteronemia Development without Changing Atherosclerosis Susceptibility.
van der Sluis RJ; van den Aardweg T; Sijsenaar TJP; Van Eck M; Hoekstra M
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759687
[TBL] [Abstract][Full Text] [Related]
10. Differential Effects of LOX-1 Inhibition on Aortic Structure and Posterior Cerebral Artery Structure and Function in an Experimental Model of Preeclampsia.
Anderson JL; McGreer JA; Tremble SM; Tainter-Gilbert AV; Cipolla MJ
Reprod Sci; 2024 Jun; ():. PubMed ID: 38858329
[TBL] [Abstract][Full Text] [Related]
11. The vascular SIRTainty.
Yang Z; Ming XF
Aging (Albany NY); 2010 Jun; 2(6):331-2. PubMed ID: 20606250
[No Abstract] [Full Text] [Related]
12. The SR-B1ΔCT/LDLR KO mouse: A new tool to shed light on coronary artery disease.
Ferraro B
Atherosclerosis; 2024 Apr; ():117564. PubMed ID: 38796408
[No Abstract] [Full Text] [Related]
13. LOX-1 deletion and macrophage trafficking in atherosclerosis.
Ding Z; Mizeracki AM; Hu C; Mehta JL
Biochem Biophys Res Commun; 2013 Oct; 440(2):210-4. PubMed ID: 24036126
[TBL] [Abstract][Full Text] [Related]
14. Radical Oxygen Species, Oxidized Low-Density Lipoproteins, and Lectin-like Oxidized Low-Density Lipoprotein Receptor 1: A Vicious Circle in Atherosclerotic Process.
Munno M; Mallia A; Greco A; Modafferi G; Banfi C; Eligini S
Antioxidants (Basel); 2024 May; 13(5):. PubMed ID: 38790688
[TBL] [Abstract][Full Text] [Related]
15. Elevated soluble LOX-1 predicts risk of first-time myocardial infarction.
Schiopu A; Björkbacka H; Narasimhan G; Loong BJ; Engström G; Melander O; Orho-Melander M; Nilsson J
Ann Med; 2023; 55(2):2296552. PubMed ID: 38134912
[TBL] [Abstract][Full Text] [Related]
16. Associations of Tissue and Soluble LOX-1 with Human Abdominal Aortic Aneurysm.
Hofmann A; Khorzom Y; Klimova A; Wolk S; Busch A; Sabarstinski P; Müglich M; Egorov D; Kopaliani I; Poitz DM; Kapalla M; Hamann B; Frank F; Jänichen C; Brunssen C; Morawietz H; Reeps C
J Am Heart Assoc; 2023 Jul; 12(14):e027537. PubMed ID: 37421287
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide ameliorates oxidized LDL-induced endothelial dysfunction by GLP-1R-dependent downregulation of LOX-1-mediated oxidative stress and inflammation.
Ying W; Meiyan S; Wen C; Kaizu X; Meifang W; Liming L
Redox Rep; 2023 Dec; 28(1):2218684. PubMed ID: 37278349
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.
Duan Y; Gong K; Xu S; Zhang F; Meng X; Han J
Signal Transduct Target Ther; 2022 Aug; 7(1):265. PubMed ID: 35918332
[TBL] [Abstract][Full Text] [Related]
19. LOX-1: Implications in atherosclerosis and myocardial ischemia.
Sharma T; Romeo F; Mehta JL
EXCLI J; 2022; 21():273-278. PubMed ID: 35368459
[TBL] [Abstract][Full Text] [Related]
20. Native and Oxidized Low-Density Lipoproteins Increase the Expression of the LDL Receptor and the LOX-1 Receptor, Respectively, in Arterial Endothelial Cells.
Catar R; Chen L; Zhao H; Wu D; Kamhieh-Milz J; Lücht C; Zickler D; Krug AW; Ziegler CG; Morawietz H; Witowski J
Cells; 2022 Jan; 11(2):. PubMed ID: 35053320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
